Surrogate Markers for Long-Term Renal Allograft Survival
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (7), 1179-1183
- https://doi.org/10.1111/j.1600-6143.2004.00484.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Biomarkers and Surrogate Endpoints in Renal Transplantation: Present Status and Considerations for Clinical Trial DesignAmerican Journal of Transplantation, 2004
- Enzyme Linked Immunosorbent Spot (ELISPOT) Assay for Interferon‐Gamma Independently Predicts Renal Function in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2003
- When renal allografts turn darc1Transplantation, 2003
- Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine1Transplantation, 2002
- Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injuryTransplantation, 2002
- Post-transplant renal function in the first year predicts long-term kidney transplant survivalKidney International, 2002
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineNew England Journal of Medicine, 2001
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983